SEER, INC. Diluted Shares Outstanding (Weighted Average)
SEER, INC. (SEER) reported Diluted Shares Outstanding (Weighted Average) of 61.19 million shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2024-11-06
- SEER, INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 61.19M shares, a 4.29% decline year-over-year.
- SEER, INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-06-30 was 64.58M shares, a 1.28% increase year-over-year.
- SEER, INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-03-31 was 64.59M shares, a 1.64% increase year-over-year.
- SEER, INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-12-31 was 64.16M shares, a 2.15% increase year-over-year.
- SEER, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 63.85M shares, a 2.27% increase from fiscal 2022.
- SEER, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 62.43M shares, a 2.58% increase from fiscal 2021.
- SEER, INC. weighted average number of shares outstanding, diluted for fiscal 2021 was 60.86M shares, a 360.51% increase from fiscal 2020.
- SEER, INC. weighted average number of shares outstanding, diluted for fiscal 2020 was 13.22M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2024-09-30 | 61.19M shares 10-Q · filed 2024-11-06 | 62.88M shares derived: average of 2 quarters · filed 2024-11-06 | 63.44M shares 10-Q · filed 2024-11-06 | 63.63M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 64.58M shares 10-Q · filed 2024-08-08 | 64.58M shares 10-Q · filed 2024-08-08 | 64.44M shares derived: average of 3 quarters · filed 2024-08-08 | 64.31M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2024-03-31 | 64.59M shares 10-Q · filed 2024-05-08 | 64.37M shares derived: average of 2 quarters · filed 2024-05-08 | 64.23M shares derived: average of 3 quarters · filed 2024-11-06 | 64.11M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-12-31 | 64.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 64.05M shares derived: average of 2 quarters · filed 2024-11-06 | 63.95M shares derived: average of 3 quarters · filed 2024-11-06 | 63.85M shares 10-K · filed 2024-03-04 |
| 2023-09-30 | 63.93M shares 10-Q · filed 2024-11-06 | 63.85M shares derived: average of 2 quarters · filed 2024-11-06 | 63.75M shares 10-Q · filed 2024-11-06 | 63.51M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | 63.76M shares 10-Q · filed 2024-08-08 | 63.65M shares 10-Q · filed 2024-08-08 | 63.37M shares derived: average of 3 quarters · filed 2024-08-08 | 63.16M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 63.54M shares 10-Q · filed 2024-05-08 | 63.18M shares derived: average of 2 quarters · filed 2024-05-08 | 62.96M shares derived: average of 3 quarters · filed 2024-05-08 | 62.82M shares derived: average of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | 62.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 62.67M shares derived: average of 2 quarters · filed 2024-03-04 | 62.58M shares derived: average of 3 quarters · filed 2024-03-04 | 62.43M shares 10-K · filed 2024-03-04 |
| 2022-09-30 | 62.54M shares 10-Q · filed 2023-11-07 | 62.46M shares derived: average of 2 quarters · filed 2023-11-07 | 62.31M shares 10-Q · filed 2023-11-07 | 62.12M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 62.38M shares 10-Q · filed 2023-08-08 | 62.19M shares 10-Q · filed 2023-08-08 | 61.99M shares derived: average of 3 quarters · filed 2023-08-08 | 61.77M shares derived: average of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | 62.00M shares 10-Q · filed 2023-05-09 | 61.79M shares derived: average of 2 quarters · filed 2023-05-09 | 61.57M shares derived: average of 3 quarters · filed 2023-05-09 | 61.39M shares derived: average of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | 61.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 61.36M shares derived: average of 2 quarters · filed 2023-03-06 | 61.18M shares derived: average of 3 quarters · filed 2023-03-06 | 60.86M shares 10-K · filed 2023-03-06 |
| 2021-09-30 | 61.13M shares 10-Q · filed 2022-11-08 | 60.99M shares derived: average of 2 quarters · filed 2022-11-08 | 60.63M shares 10-Q · filed 2022-11-08 | 51.40M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 60.84M shares 10-Q · filed 2022-08-09 | 60.37M shares 10-Q · filed 2022-08-09 | 48.16M shares derived: average of 3 quarters · filed 2022-08-09 | 38.69M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 59.89M shares 10-Q · filed 2022-05-06 | 41.81M shares derived: average of 2 quarters · filed 2022-05-06 | 31.30M shares derived: average of 3 quarters · filed 2022-05-06 | 25.91M shares derived: average of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | 23.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 17.01M shares derived: average of 2 quarters · filed 2022-03-01 | 14.58M shares derived: average of 3 quarters · filed 2022-03-01 | 13.22M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 10.29M shares 10-Q · filed 2021-11-09 | 10.00M shares derived: average of 2 quarters · filed 2021-11-09 | 9.71M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 9.72M shares 10-Q · filed 2021-08-12 | 9.32M shares 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 8.94M shares 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |